Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
EVerZom Raises €10M to Advance Exosome-Based Regenerative Therapies
Growth StageVenture Capital

EVerZom Raises €10M to Advance Exosome-Based Regenerative Therapies

•October 14, 2025
•Oct 14, 2025
0

Participants

Everzom

Everzom

company

Capital Grand Est

Capital Grand Est

investor

Sorbonne Venture

Sorbonne Venture

investor

Aloe Group

Aloe Group

investor

Paris Business Angels

Paris Business Angels

investor

Capital Cell

Capital Cell

investor

Fuel Cells and Hydrogen Joint Undertaking

Fuel Cells and Hydrogen Joint Undertaking

investor

Deal Summary

Strasbourg-based biotech EVerZom raised €10M in a funding round led by Capital Grand Est, the EIC Fund, Sorbonne Venture by Audacia, Aloe Private Equit, Paris Business Angels, Capital Cell and several family offices. The company will use the proceeds to advance development of its exosome-based therapies for regenerative medicine.

0

Comments

Want to join the conversation?

Loading comments...